Stevanato Group S.p.A.

NYSE:STVN

Medical - Instruments & Supplies

Healthcare
$15.36 +3.90%

+$0.67 today

Market cap
$4.20B
Beta
0.78
P/E (TTM)
29.9
EPS (TTM)
$0.52
Dividend yield
0.35%
52W Low $12.89High $28.00

Volume 0.61M

Average 0.52M

STVN Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Stevanato Group S.p.A.NYSE: STVN

Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q2 FY2026 weighted avg shares (diluted) of 273M shares rose 0.0% year over year, in line with the +0.0% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 0.0% from the prior quarter. Over 3 fiscal years it compounded at +1.0% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +0.0% toward the trailing-twelve-month pace of +0.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
273M-0.0% QoQ
Last fiscal yearDec 2025
273M+0.0% YoY
LTMJun 2026
273.01M+0.0% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.0%——
1 year+0.0%——
3-year CAGR+1.0%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
273M EUR
Year-over-year change
+0.0%
4-year CAGR
+0.8%

Weighted Avg Shares (Diluted) vs competitors

How STVN compares with its peers on the latest reported figures

  • STVN's LTM Jun 2026 weighted avg shares (diluted) of 273.01M shares is the 3rd highest of the 11 companies compared; the peer median is 62.77M shares.
  • Its year-over-year change of +0.0% is the 5th highest of 11, against a peer median of -0.5%.
  • Over three fiscal years its annual growth of +1.0% compares with a peer median of +0.2%.
STVN Competitors Peer median
Weighted Avg Shares (Diluted) for STVN and competitors
Company Period LTM YoY 3-year CAGR
AVTRAvantor, Inc.LTM Jun 2026679.38M -0.5%-0.0%
BLCOBausch + Lomb CorporationLTM Jun 2026355.23M +0.6%+0.4%
STVNStevanato Group S.p.A.LTM Jun 2026273.01M +0.0%+1.0%
BTSGBrightSpring Health Services, Inc. Common StockLTM Sep 2026220.06M +2.1%+8.7%
NUVLNuvalent, Inc.LTM Mar 202674.44M +9.1%+13.5%
ATRAptarGroup, Inc.LTM Jun 202665.44M -3.1%+0.0%
MMSIMerit Medical Systems, Inc.LTM Sep 202660.11M -0.8%+1.6%
MASIMasimo CorporationLTM Apr 202654M -0.5%-0.6%
AXSMAxsome Therapeutics, Inc.LTM Jun 202650.84M +4.3%+7.0%
TFXTeleflex IncorporatedLTM Jun 202644.1M -4.8%-1.9%
CHEChemed CorporationLTM Jun 202613.91M -6.4%-1.6%
Peer median (excluding STVN) 62.77M-0.5%+0.2%

Competitors are the stored peer set for STVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue843.92M983.68M1.09B1.1B1.14B
Cost of Revenue578.52M663.88M745.46M801.72M809.15M
Gross Profit265.41M319.8M339.89M302.32M330.33M
Gross Margin31.4%32.5%31.3%27.4%29.0%
Research & Development29.62M34.39M35.67M31.67M24.4M
Selling, General & Admin82.95M111.83M113.92M118.6M122.85M
Operating Expenses103.18M127.37M139.17M141.18M147.25M
Depreciation & Amortization56.38M64.82M78.48M80.65M88.57M
EBITDA226.93M256.4M272.35M247.8M292.01M
EBITDA Margin26.9%26.1%25.1%22.4%25.6%
Operating Income162.23M192.43M200.72M161.14M183.08M
Operating Margin19.2%19.6%18.5%14.6%16.1%
Interest Income548K648K792K1.72M12.49M
Interest Expense4.87M3.94M4.32M6.86M21.8M
Other Income / Expenses3.45M(4.79M)(11.17M)(854K)(1.44M)
Income Before Tax165.67M187.64M189.55M160.29M181.64M
Pre-Tax Margin19.6%19.1%17.5%14.5%15.9%
Income Tax Expense31.4M44.63M43.86M42.52M47.35M
Net Income134.32M142.85M145.63M117.78M134.28M
Net Margin15.9%14.5%13.4%10.7%11.8%
EPS (Basic)0.530.530.550.430.49
EPS (Diluted)0.530.530.550.430.49
Weighted Avg Shares264.7M264.7M264.95M272.87M273M
Weighted Avg Shares (Diluted)264.7M264.7M264.98M272.88M273M

Stevanato Group S.p.A.

NYSE:STVN

Intrinsic Alpha fair value

Locked

Current Price

$15.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.